Study of Trilaciclib and Lurbinectidin

Clinical trial NCT05578326 · RECRUITING

Trial details

NCT number: NCT05578326
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Small-cell Lung Cancer

Start date: 2022-10-12
Primary completion: 2026-12-25
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.